Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases.
Guido BocciPaola OrlandiMaria Laura MancaChiara RossiAntonio SalvatiMaurizia Rossana BrunettoAnna SoliniPublished in: Journal of clinical medicine (2022)
Our data show that circulating biomarker profiles can identify the severity of chronic liver disease of NAFLD/NASH or HCV origin.